Divi's Laboratories Limited

NSE: DIVISLABHealthcareLot size: 100

Divi's Laboratories Limited Max Pain Analysis

₹9100.00Updated 4 Sept 2026, 03:30 pm IST
Max Pain Strike
₹9000Writers’ least-loss point
Spot vs Max Pain
+1.11%Spot ₹9,100
Max Pain Shift
+₹0vs yesterday
Days to Expiry
232026-09-29
2nd Lowest Pain Strike
₹8900₹100 from max pain

What is Max Pain?

Max Pain theory states the underlying gravitates toward the strike where option writers face minimum collective loss at expiry. For DIVISLAB, that strike is ₹9,000. Spot at ₹9,100 is 1.11% above max pain — possible downward gravitational pull into expiry.

AI AnalysisGenerated daily after market close · AI-powered

Max Pain Level

The current max‑pain strike for DIVISLAB is ₹9,000, the level at which option writers would incur the smallest aggregate loss if all open contracts expire worthless. This “pain” point tends to act as a magnet for the underlying price as expiry approaches.

Spot vs Max Pain Gap

The spot price of ₹9,100 sits just 1.11 % above the max‑pain level, indicating a modest premium over the strike that may incentivize some sellers to let the price drift lower. With the price already close, any downward pull‑back could tighten the gap and reinforce the magnetic effect.

Shift Signal

The shift metric shows no change from the previous day, suggesting that the open‑interest distribution across strikes has remained stable. Writers appear to be maintaining their current positioning, with no new pressure to adjust strikes in response to market flow.

Expiry Context

Max pain is derived from the net open interest of both calls and puts; the strike that minimizes the combined loss for writers becomes the “pain” point. In the final week before expiry, the underlying often gravitates toward this level as time decay accelerates and market participants hedge or close positions. While this tendency is frequently observed, it does not guarantee the final settlement price.

Data Note

The spot‑to‑max‑pain distance is ₹100 (≈1.11 %) with 25 days remaining until the September 29 expiry.

Data as of 2026-09-04

Frequently Asked Questions

What is Divi's Laboratories Limited max pain today?
Divi's Laboratories Limited's max pain strike is ₹9,000 for the 2026-09-29 expiry (23 days away). Spot is 1.1% above max pain.
How is max pain calculated for Divi's Laboratories Limited?
Divi's Laboratories Limited's max pain is calculated by taking every possible expiry price and computing the total ITM payout to all option buyers: sum of (CE OI × max(0, spot − strike)) + (PE OI × max(0, strike − spot)) for all strikes. The strike with the minimum total payout is the max pain — where option writers collectively lose the least.
Does max pain predict Divi's Laboratories Limited expiry price?
Max pain theory suggests the underlying tends to gravitate toward the max pain strike as expiry approaches, because option writers (who have the capital and hedging ability) can influence spot price. It's more reliable within 1 week of expiry and for liquid stocks like Divi's Laboratories Limited. It should be used with other signals, not in isolation.
What happened to Divi's Laboratories Limited max pain since yesterday?
Divi's Laboratories Limited's max pain is unchanged from the previous session. Max pain shifts indicate that option writers are adjusting their positions — a rising max pain is modestly bullish; falling is modestly bearish.
What is the next expiry for Divi's Laboratories Limited options?
Divi's Laboratories Limited's next options expiry is on 2026-09-29 — 23 days away. NSE F&O stocks have monthly expiry on the last Tuesday of each month. As expiry approaches, gamma risk increases and max pain becomes a stronger gravitational force.